Healthy adipose tissue after menopause: contribution of balanced diet and physical exercise

Abstract

The accumulation of adipose tissue is associated with metabolic disorders, including insulin resistance, type 2 diabetes (T2D), dyslipidemia, metabolic syndrome, and cardiovascular diseases (CVD). Menopause might predispose women to increase body weight and adipose tissue, and decrease lean muscle mass. Furthermore, postmenopausal women display fat mass redistribution with greater accumulation in the visceral area mainly due to hormonal shifts that result in a higher testosterone/estradiol ratio. These effects are associated with a less favorable adipokine profile, dyslipidemia, insulin resistance, and cardiac dysfunction after menopause. Fat mass is determined by the balance between the storage of triacylglycerol (TAG) (lipogenesis) and the removal of stored TAG (lipolysis) in combination with the differentiation of new adipocytes (adipogenesis). Disturbances in adipose tissue dynamics lead to an increase in lipogenesis (hypertrophy) and/or in adipogenesis (hyperplasia) to accommodate excess energy intake. While large adipocytes are dysfunctional and have greater secretion of inflammatory adipocytokines, small adipocytes are healthier and associated with metabolic improvements. Different strategies can be used to prevent or reduce body weight gain and fat mass, as well as to maintain healthy adipose tissue; however, due to robust evidence, lifestyle interventions should be pillars in this process. This review provides a comprehensive summary of findings on the role of a balanced diet and physical exercise in improving body composition and promoting healthy adipose tissue in postmenopausal women.

Keywords

Menopause / adipose tissue / dietary intake / physical exercise

References

[1] Ambikairajah A, Walsh E, Tabatabaei-Jafari H, Cherbuin N. Fat mass changes during menopause: a metaanalysis. Am J Obstet Gynecol. 2019; 221: 393-409.e50.

[2] Silveira EA, Mendonça CR, Delpino FM, Elias Souza GV, Pereira de Souza Rosa L, de Oliveira C, et al. Sedentary behavior, physical inactivity, abdominal obesity and obesity in adults and older adults: A systematic review and meta-analysis. Clin Nutr ESPEN. 2022; 50: 63-73.

[3] Barrea L, Pugliese G, Laudisio D, Colao A, Savastano S, Muscogiuri G. Mediterranean diet as medical prescription in menopausal women with obesity: a practical guide for nutritionists. Crit Rev Food Sci Nutr. 2021; 61: 1201-11.

[4] Veronese N, Ragusa FS, Pegreffi F, Dominguez LJ, Barbagallo M, Zanetti M, et al. Sarcopenic obesity and health outcomes: An umbrella review of systematic reviews with meta-analysis. J Cachexia Sarcopenia Muscle. 2024; 15: 1264-74.

[5] Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, et al.; Writing Group of the International Menopause Society for World Menopause Day 2012. Understanding weight gain at menopause. Climacteric. 2012; 15: 419-29.

[6] Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond). 2008; 32: 949-58.

[7] Sun Q, Liu C, Li S, Ren J, Wang Z. The different association between fat mass distribution and intake of three major nutrients in pre- and postmenopausal women. PLoS One. 2024; 19: e0304098.

[8] Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018. NCHS Data Brief. 2020: 1-8.

[9] Matthews KA, Kuller LH, Sutton-Tyrrell K, Chang YF. Changes in Cardiovascular Risk Factors During the Perimenopause and Postmenopause and Carotid Artery Atherosclerosis in Healthy Women. Stroke. 2001; 32: 1104-11.

[10] Ebong IA, Wilson M, Michos ED, Appiah D, Schreiner PJ, Racette SB, et al. Menopausal age, adipokines, and heart failure incidence in postmenopausal women of the Multi-Ethnic Study of Atherosclerosis. Menopause. 2025; 32: 72-80.

[11] Horwitz A, Birk R. Adipose Tissue Hyperplasia and Hypertrophy in Common and Syndromic Obesity-The Case of BBS Obesity. Nutrients. 2023; 15: 3445.

[12] Reilly SM, Saltiel AR. Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol. 2017; 13: 633-43.

[13] Chandrasekaran P, Weiskirchen R. The Role of Obesity in Type 2 Diabetes Mellitus-An Overview. Int J Mol Sci. 2024; 25: 1882.

[14] Ghaben AL, Scherer PE. Adipogenesis and metabolic health. Nat Rev Mol Cell Biol. 2019; 20: 242-58.

[15] Sakers A, De Siqueira MK, Seale P, Villanueva CJ. Adipose-tissue plasticity in health and disease. Cell. 2022; 185: 419-46.

[16] Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med. 2011; 17: 55-63.

[17] Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010; 11: 11-8.

[18] Swift DL, Johannsen NM, Lavie CJ, Earnest CP, Church TS. The Role of Exercise and Physical Activity in Weight Loss and Maintenance. Prog Cardiovasc Dis. 2014; 56: 441-7.

[19] Prokopidis K, Cervo MM, Gandham A, Scott D. Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective. Nutrients. 2020; 12: 2285.

[20] Robinson E, McFarland-Lesser I, Patel Z, Jones A. Downsizing food: a systematic review and meta-analysis examining the effect of reducing served food portion sizes on daily energy intake and body weight. Br J Nutr. 2023; 129: 888-903.

[21] Chen X, He H, Xie K, Zhang L, Cao C. Effects of various exercise types on visceral adipose tissue in individuals with overweight and obesity: A systematic review and network meta-analysis of 84 randomized controlled trials. Obes Rev. 2024; 25: e13666.

[22] Zwick RK, Guerrero-Juarez CF, Horsley V, Plikus MV. Anatomical, Physiological, and Functional Diversity of Adipose Tissue. Cell Metab. 2018; 27: 68-83.

[23] Esteve Ràfols M. Tejido adiposo: Heterogeneidad celular y diversidad funcional. Endocrinologia y Nutricion. 2014; 61: 100-12. Spanish.

[24] Palacios-Marin I, Serra D, Jimenez-Chillarón J, Herrero L, Todorčević M. Adipose Tissue Dynamics: Cellular and Lipid Turnover in Health and Disease. Nutrients. 2023; 15: 3968.

[25] Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A. 1994; 91: 4854-8.

[26] Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011; 29: 415-45.

[27] Schoettl T, Fischer IP, Ussar S. Heterogeneity of adipose tissue in development and metabolic function. J Exp Biol. 2018; 221: jeb162958.

[28] Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, et al. Leptin and Obesity: Role and Clinical Implication. Front Endocrinol (Lausanne). 2021; 12: 585887.

[29] Dornbush S, Aeddula NR. Physiology, Leptin. Treasure Island (FL): StatPearls Publishing; 2025.

[30] Nguyen TMD. Adiponectin: Role in Physiology and Pathophysiology. Int J Prev Med. 2020; 11: 136.

[31] Bauzá-Thorbrügge M, Vujičić M, Chanclón B, Palsdottir V, Pillon NJ, Benrick A, et al. Adiponectin stimulates Sca1⁺CD34⁻-adipocyte precursor cells associated with hyperplastic expansion and beiging of brown and white adipose tissue. Metabolism. 2024; 151: 155716.

[32] Abu-Odeh M, Zhang Y, Reilly SM, Ebadat N, Keinan O, Valentine JM, et al. FGF21 promotes thermogenic gene expression as an autocrine factor in adipocytes. Cell Rep. 2021; 35: 109331.

[33] Spann RA, Morrison CD, den Hartigh LJ. The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model. Front Endocrinol (Lausanne). 2022; 12: 802541.

[34] Sam S. Differential effect of subcutaneous abdominal and visceral adipose tissue on cardiometabolic risk. Horm Mol Biol Clin Investig. 2018; 33.

[35] Kwok KH, Lam KS, Xu A. Heterogeneity of white adipose tissue: molecular basis and clinical implications. Exp Mol Med. 2016; 48: e215.

[36] Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, Martín-Rodríguez A, Martínez-Guardado I, Navarro-Jiménez E, et al. The Role of Adipokines in Health and Disease. Biomedicines. 2023; 11: 1290.

[37] Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev. 2014; 15: 504-15.

[38] van den Berg SM, van Dam AD, Rensen PC, Winther MP, Lutgens E. Immune Modulation of Brown(ing) Adipose Tissue in Obesity. Endocr Rev. 2017; 38: 46-68.

[39] Cannon B, Nedergaard J. Brown Adipose Tissue: Function and Physiological Significance. Physiol Rev. 2004; 84: 277-359.

[40] Dunn J, Grider MH. Physiology, Adenosine Triphosphate. Treasure Island (FL): StatPearls Publishing; 2025.

[41] Jagtap U, Paul A. UCP1 activation: Hottest target in the thermogenesis pathway to treat obesity using molecules of synthetic and natural origin. Drug Discov Today. 2023; 28: 103717.

[42] Maliszewska K, Kretowski A. Brown Adipose Tissue and Its Role in Insulin and Glucose Homeostasis. Int J Mol Sci. 2021; 22: 1530.

[43] Quan Y, Lu F, Zhang Y. Use of brown adipose tissue transplantation and engineering as a thermogenic therapy in obesity and metabolic disease. Obes Rev. 2024; 25: e13677.

[44] Villarroya F, Cereijo R, Villarroya J, Giralt M. Brown adipose tissue as a secretory organ. Nat Rev Endocrinol. 2017; 13: 26-35.

[45] Liu J, Lu J, Zhang L, Liu Y, Zhang Y, Gao Y, et al. The combination of exercise and metformin inhibits TGF-β1/Smad pathway to attenuate myocardial fibrosis in db/db mice by reducing NF-κB-mediated inflammatory response. Biomed Pharmacother. 2023; 157: 114080.

[46] Pereira RO, Olvera AC, Marti A, Fang S, White JR, Westphal M, et al. OPA1 Regulates Lipid Metabolism and Cold-Induced Browning of White Adipose Tissue in Mice. Diabetes. 2022; 71: 2572-83.

[47] Scheel AK, Espelage L, Chadt A. Many Ways to Rome: Exercise, Cold Exposure and Diet-Do They All Affect BAT Activation and WAT Browning in the Same Manner? Int J Mol Sci. 2022; 23: 4759.

[48] Mu WJ, Zhu JY, Chen M, Guo L. Exercise-Mediated Browning of White Adipose Tissue: Its Significance, Mechanism and Effectiveness. Int J Mol Sci. 2021; 22: 11512.

[49] Guo D, Yamamoto M, Hernandez CM, Khodadadi H, Baban B, Stranahan AM. Beige adipocytes mediate the neuroprotective and anti-inflammatory effects of subcutaneous fat in obese mice. Nat Commun. 2021; 12: 4623.

[50] Ziqubu K, Dludla PV, Mthembu SXH, Nkambule BB, Mabhida SE, Jack BU, et al. An insight into brown/beige adipose tissue whitening, a metabolic complication of obesity with the multifactorial origin. Front Endocrinol (Lausanne). 2023; 14: 1114767.

[51] Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011; 12: 722-34.

[52] Kaartinen MT, Arora M, Heinonen S, Rissanen A, Kaprio J, Pietiläinen KH. Transglutaminases and Obesity in Humans: Association of F13A1 to Adipocyte Hypertrophy and Adipose Tissue Immune Response. Int J Mol Sci. 2020; 21: 8289.

[53] Norreen-Thorsen M, Struck EC, Öling S, Zwahlen M, Von Feilitzen K, Odeberg J, et al. A human adipose tissue cell-type transcriptome atlas. Cell Rep. 2022; 40: 111046.

[54] Sarjeant K, Stephens JM. Adipogenesis. Cold Spring Harb Perspect Biol. 2012; 4: a008417.

[55] Mota de Sá P, Richard AJ, Hang H, Stephens JM. Transcriptional Regulation of Adipogenesis. Compr Physiol. 2017; 7: 635-74.

[56] Lazar AD, Dinescu S, Costache M. Adipose tissue engineering and adipogenesis-a review. Rev Bio Biomed Sci. 2018; 1: 17-26.

[57] Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, et al. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-β transcriptional complex. Nature. 2009; 460: 1154-8.

[58] Tabuchi C, Sul HS. Corrigendum: Signaling Pathways Regulating Thermogenesis. Front Endocrinol (Lausanne). 2021; 12: 698619.

[59] Charó NL, Rodríguez Ceschan MI, Galigniana NM, Toneatto J, Piwien-Pilipuk G. Organization of nuclear architecture during adipocyte differentiation. Nucleus. 2016; 7: 249-69.

[60] Cinti S. Between brown and white: novel aspects of adipocyte differentiation. Ann Med. 2011; 43: 104-15.

[61] Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U. Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab. 2015; 26: 193-200.

[62] Stenkula KG, Erlanson-Albertsson C. Adipose cell size: importance in health and disease. Am J Physiol Regul Integr Comp Physiol. 2018; 315: R284-95.

[63] Jakab J, Miškić B, Mikšić Š, Juranić B, Ćosić V, Schwarz D, et al. Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products. Diabetes Metab Syndr Obes. 2021; 14: 67-83.

[64] Danforth E Jr. Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet. 2000; 26: 13.

[65] Schwenk RW, Holloway GP, Luiken JJ, Bonen A, Glatz JF. Fatty acid transport across the cell membrane: Regulation by fatty acid transporters. Prostaglandins Leukot Essent Fatty Acids. 2010; 82: 149-54.

[66] Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N. De novo lipogenesis in health and disease. Metabolism. 2014; 63: 895-902.

[67] Bódis K, Roden M. Energy metabolism of white adipose tissue and insulin resistance in humans. Eur J Clin Invest. 2018; 48: e13017.

[68] Batchuluun B, Pinkosky SL, Steinberg GR. Lipogenesis inhibitors: therapeutic opportunities and challenges. Nat Rev Drug Discov. 2022; 21: 283-305.

[69] Coleman RA, Lee DP. Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res. 2004; 43: 134-76.

[70] Jensen-Urstad AP, Semenkovich CF. Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? Biochim Biophys Acta. 2012; 1821: 747-53.

[71] Jones JG. Some paradoxes and unresolved aspects of hepatic de novo lipogenesis. npj Metabolic Health and Disease. 2024; 2: 18.

[72] Chaves VE, Frasson D, Kawashita NH. Several agents and pathways regulate lipolysis in adipocytes. Biochimie. 2011; 93: 1631-40.

[73] Frühbeck G, Méndez-Giménez L, Fernández-Formoso JA, Fernández S, Rodríguez A. Regulation of adipocyte lipolysis. Nutr Res Rev. 2014; 27: 63-93.

[74] Nielsen TS, Jessen N, Jørgensen JO, Møller N, Lund S. Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease. J Mol Endocrinol. 2014; 52: R199-222.

[75] Greendale GA, Sternfeld B, Huang M, Han W, Karvonen-Gutierrez C, Ruppert K, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019; 4: e124865.

[76] Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause. 2006; 13: 280-5.

[77] Sternfeld B, Wang H, Quesenberry CP Jr, Abrams B, Everson-Rose SA, Greendale GA, et al. Physical Activity and Changes in Weight and Waist Circumference in Midlife Women: Findings from the Study of Women’s Health Across the Nation. Am J Epidemiol. 2004; 160: 912-22.

[78] Hurtado MD, Saadedine M, Kapoor E, Shufelt CL, Faubion SS. Weight Gain in Midlife Women. Curr Obes Rep. 2024; 13: 352-63.

[79] Toth MJ, Tchernof A, Sites CK, Poehlman ET. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord. 2000; 24: 226-31.

[80] Wright VJ, Schwartzman JD, Itinoche R, Wittstein J. The musculoskeletal syndrome of menopause. Climacteric. 2024; 27: 466-72.

[81] Jakicic JM, Apovian CM, Barr-Anderson DJ, Courcoulas AP, Donnelly JE, Ekkekakis P, et al. Physical Activity and Excess Body Weight and Adiposity for Adults. American College of Sports Medicine Consensus Statement. Med Sci Sports Exerc. 2024; 56: 2076-91.

[82] Li Y, Yang P, Ye J, Xu Q, Wu J, Wang Y. Updated mechanisms of MASLD pathogenesis. Lipids Health Dis. 2024; 23: 117.

[83] Leeners B, Geary N, Tobler PN, Asarian L. Ovarian hormones and obesity. Hum Reprod Update. 2017; 23: 300-21.

[84] Janssen I, Powell LH, Jasielec MS, Kazlauskaite R. Covariation of change in bioavailable testosterone and adiposity in midlife women. Obesity (Silver Spring). 2015; 23: 488-94.

[85] Rebuffé-Scrive M, Eldh J, Hafström LO, Björntorp P. Metabolism of mammary, abdominal, and femoral adipocytes in women before and after menopause. Metabolism. 1986; 35: 792-7.

[86] Coutinho T, Goel K, Corrêa de Sá D, Kragelund C, Kanaya AM, Zeller M, et al. Central Obesity and Survival in Subjects With Coronary Artery Disease: A Systematic Review of the Literature and Collaborative Analysis With Individual Subject Data. J Am Coll Cardiol. 2011; 57: 1877-86.

[87] Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, et al.; Diabetes Prevention Program Research Group. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr. 2008; 87: 1212-8.

[88] Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, et al. Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women. J Am Coll Cardiol. 2018; 71: 2555-66.

[89] McAloon CJ, Boylan LM, Hamborg T, Stallard N, Osman F, Lim PB, et al. The changing face of cardiovascular disease 2000-2012: An analysis of the world health organisation global health estimates data. Int J Cardiol. 2016; 224: 256-64.

[90] Tchkonia T, Tchoukalova YD, Giorgadze N, Pirtskhalava T, Karagiannides I, Forse RA, et al. Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab. 2005; 288: E267-77.

[91] Veilleux A, Caron-Jobin M, Noël S, Laberge PY, Tchernof A. Visceral Adipocyte Hypertrophy is Associated With Dyslipidemia Independent of Body Composition and Fat Distribution in Women. Diabetes. 2011; 60: 1504-11.

[92] Chopra S, Sharma KA, Ranjan P, Malhotra A, Vikram NK, Kumari A. Weight Management Module for Perimenopausal Women: A Practical Guide for Gynecologists. J Midlife Health. 2019; 10: 165-72.

[93] Heymsfield SB, Wadden TA. Mechanisms, Pathophysiology, and Management of Obesity. N Engl J Med. 2017; 376: 254-66.

[94] Malutan AM, Dan M, Nicolae C, Carmen M. Proinflammatory and anti-inflammatory cytokine changes related to menopause. Prz Menopauzalny. 2014; 13: 162-8.

[95] Pernoud LE, Gardiner PA, Fraser SD, Dillon-Rossiter K, Dean MM, Schaumberg MA. A systematic review and meta-analysis investigating differences in chronic inflammation and adiposity before and after menopause. Maturitas. 2024; 190: 108119.

[96] Hasan Azeez S. Influence of IL-10, IL-6 and TNF-α gene polymorphism on obesity. Cell Mol Biol (Noisy-le-grand). 2023; 69: 277-82.

[97] García-Estevez L, González-Martínez S, Moreno-Bueno G. The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer. Front Immunol. 2021; 12: 784823.

[98] Upadhyay J, Farr OM, Mantzoros CS. The role of leptin in regulating bone metabolism. Metabolism. 2015; 64: 105-13.

[99] Shu L, Fu Y, Sun H. The association between common serum adipokines levels and postmenopausal osteoporosis: A meta-analysis. J Cell Mol Med. 2022; 26: 4333-42.

[100] Thurston RC, Chang Y, Mancuso P, Matthews KA. Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women’s Health Across the Nation. Fertil Steril. 2013; 100: 793-800.

[101] Rosenbaum M, Knight R, Leibel RL. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab. 2015; 26: 493-501.

[102] Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024; 73: 691-702.

[103] Martínez de Morentin PB, González-García I, Martins L, Lage R, Fernández-Mallo D, Martínez-Sánchez N, et al. Estradiol Regulates Brown Adipose Tissue Thermogenesis via Hypothalamic AMPK. Cell Metab. 2014; 20: 41-53.

[104] Rodríguez-Cuenca S, Monjo M, Gianotti M, Proenza AM, Roca P. Expression of mitochondrial biogenesis-signaling factors in brown adipocytes is influenced specifically by 17β-estradiol, testosterone, and progesterone. Am J Physiol Endocrinol Metab. 2007; 292: E340-6.

[105] Mahboobifard F, Pourgholami MH, Jorjani M, Dargahi L, Amiri M, Sadeghi S, et al. Estrogen as a key regulator of energy homeostasis and metabolic health. Biomed Pharmacother. 2022; 156: 113808.

[106] Omran F, Christian M. Inflammatory Signaling and Brown Fat Activity. Front Endocrinol (Lausanne). 2020; 11: 156.

[107] Villarroya F, Cereijo R, Gavaldà-Navarro A, Villarroya J, Giralt M. Inflammation of brown/beige adipose tissues in obesity and metabolic disease. J Intern Med. 2018; 284: 492-504.

[108] Yang L, Toriola AT. Menopausal Hormone Therapy Use Among Postmenopausal Women. JAMA Health Forum. 2024; 5: e243128.

[109] Gu Y, Han F, Xue M, Wang M, Huang Y. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis. BMC Womens Health. 2024; 24: 60.

[110] Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, et al. Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women’s Health Initiative. Am J Clin Nutr. 2005; 82: 651-6.

[111] Ahtiainen M, Alen M, Pöllänen E, Pulkkinen S, Ronkainen PH, Kujala UM, et al. Hormone therapy is associated with better body composition and adipokine/glucose profiles: a study with monozygotic co-twin control design. Menopause. 2012; 19: 1329-35.

[112] Costa GBC, Carneiro G, Umeda L, Pardini D, Zanella MT. Influence of Menopausal Hormone Therapy on Body Composition and Metabolic Parameters. Biores Open Access. 2020; 9: 80-5.

[113] Papadakis GE, Hans D, Gonzalez Rodriguez E, Vollenweider P, Waeber G, Marques-Vidal P, et al. Menopausal Hormone Therapy Is Associated With Reduced Total and Visceral Adiposity: The OsteoLaus Cohort. J Clin Endocrinol Metab. 2018; 103: 1948-57.

[114] Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014; 129: S102-38.

[115] Turner L, Charrouf R, Martínez-Vizcaíno V, Hutchison A, Heilbronn LK, Fernández-Rodríguez R. The effects of time-restricted eating versus habitual diet on inflammatory cytokines and adipokines in the general adult population: a systematic review with meta-analysis. Am J Clin Nutr. 2024; 119: 206-20.

[116] European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024; 81: 492-542.

[117] Winters-van Eekelen E, Verkouter I, Peters HPF, Alssema M, de Roos BG, Schrauwen-Hinderling VB, et al. Effects of dietary macronutrients on liver fat content in adults: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2021; 75: 588-601.

[118] Little TJ, Horowitz M, Feinle-Bisset C. Modulation by high-fat diets of gastrointestinal function and hormones associated with the regulation of energy intake: implications for the pathophysiology of obesity. Am J Clin Nutr. 2007; 86: 531-41.

[119] Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, et al. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007; 86: 276-84.

[120] Richter M, Baerlocher K, Bauer JM, Elmadfa I, Heseker H, Leschik-Bonnet E, et al. Revised Reference Values for the Intake of Protein. Ann Nutr Metab. 2019; 74: 242-50.

[121] Iglay HB, Apolzan JW, Gerrard DE, Eash JK, Anderson JC, Campbell WW. Moderately increased protein intake predominately from egg sources does not influence whole body, regional, or muscle composition responses to resistance training in older people. J Nutr Health Aging. 2009; 13: 108-14.

[122] Rossato LT, Nahas PC, de Branco FMS, Martins FM, Souza AP, Carneiro MAS, et al. Higher Protein Intake Does Not Improve Lean Mass Gain When Compared with RDA Recommendation in Postmenopausal Women Following Resistance Exercise Protocol: A Randomized Clinical Trial. Nutrients. 2017; 9: 1007.

[123] Smith GI, Yoshino J, Kelly SC, Reeds DN, Okunade A, Patterson BW, et al. High-Protein Intake during Weight Loss Therapy Eliminates the Weight-Loss-Induced Improvement in Insulin Action in Obese Postmenopausal Women. Cell Rep. 2016; 17: 849-61.

[124] Silva TR, Spritzer PM. Skeletal muscle mass is associated with higher dietary protein intake and lower body fat in postmenopausal women: a cross-sectional study. Menopause. 2017; 24: 502-9.

[125] Nabuco HC, Tomeleri CM, Junior PS, Fernandes RR, Cavalcante EF, Nunes JP, et al. Effects of higher habitual protein intake on resistance-training-induced changes in body composition and muscular strength in untrained older women: A clinical trial study. Nutr Health. 2019; 25: 103-12.

[126] Bray GA, Redman LM, de Jonge L, Rood J, Smith SR. Effect of Three Levels of Dietary Protein on Metabolic Phenotype of Healthy Individuals With 8 Weeks of Overfeeding. J Clin Endocrinol Metab. 2016; 101: 2836-43.

[127] Jäger R, Kerksick CM, Campbell BI, Cribb PJ, Wells SD, Skwiat TM, et al. International Society of Sports Nutrition Position Stand: protein and exercise. J Int Soc Sports Nutr. 2017; 14: 20.

[128] Mentella MC, Scaldaferri F, Ricci C, Gasbarrini A, Miggiano GAD. Cancer and Mediterranean Diet: A Review. Nutrients. 2019; 11: 2059.

[129] Kiani AK, Medori MC, Bonetti G, Aquilanti B, Velluti V, Matera G, et al. Modern vision of the Mediterranean diet. J Prev Med Hyg. 2022; 63: E36-43.

[130] Osorio-Conles Ó, Olbeyra R, Moizé V, Ibarzabal A, Giró O, Viaplana J, et al. Positive Effects of a Mediterranean Diet Supplemented with Almonds on Female Adipose Tissue Biology in Severe Obesity. Nutrients. 2022; 14: 2617.

[131] Daidone M, Casuccio A, Puleo MG, Del Cuore A, Pacinella G, Di Chiara T, et al. Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides. PLoS One. 2024; 19: e0300844.

[132] Isanejad M, Sirola J, Mursu J, Rikkonen T, Kröger H, Tuppurainen M, et al. Association of the Baltic Sea and Mediterranean diets with indices of sarcopenia in elderly women, OSPTRE-FPS study. Eur J Nutr. 2018; 57: 1435-48.

[133] Silva TRD, Martins CC, Ferreira LL, Spritzer PM. Mediterranean diet is associated with bone mineral density and muscle mass in postmenopausal women. Climacteric. 2019; 22: 162-8.

[134] Kelaiditi E, Jennings A, Steves CJ, Skinner J, Cassidy A, MacGregor AJ, et al. Measurements of skeletal muscle mass and power are positively related to a Mediterranean dietary pattern in women. Osteoporos Int. 2016; 27: 3251-60.

[135] Heidari Z, Mohammadi E, Aghamohammadi V, Jalali S, Rezazadeh A, Sedaghat F, et al. Dietary Approaches to Stop Hypertension (DASH) diets and breast cancer among women: a case control study. BMC Cancer. 2020; 20: 708.

[136] Cabre HE, Woolf EK, Redman LM. Precision Nutrition for Management of Cardiovascular Disease Risk during Menopause. Lifestyle Genom. 2024; 17: 93-101.

[137] Hirahatake KM, Jiang L, Wong ND, Shikany JM, Eaton CB, Allison MA, et al. Diet Quality and Cardiovascular Disease Risk in Postmenopausal Women With Type 2 Diabetes Mellitus: The Women’s Health Initiative. J Am Heart Assoc. 2019; 8: e013249.

[138] Levitan EB, Lewis CE, Tinker LF, Eaton CB, Ahmed A, Manson JE, et al. Mediterranean and DASH Diet Scores and Mortality in Women with Heart Failure: The Women’s Health Initiative. Circ Heart Fail. 2013; 6: 1116-23.

[139] Siervo M, Lara J, Chowdhury S, Ashor A, Oggioni C, Mathers JC. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis. Br J Nutr. 2015; 113: 1-15.

[140] Ferguson CC, Knol LL, Ellis AC. Visceral adiposity index and its association with Dietary Approaches to Stop Hypertension (DASH) diet scores among older adults: National Health and Nutrition Examination Surveys 2011-2014. Clinical Nutrition. 2021; 40: 4085-9.

[141] Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al.; AlkaMeSy Study Group. Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33: 920-2.

[142] AlEssa HB, Malik VS, Yuan C, Willett WC, Huang T, Hu FB, et al. Dietary patterns and cardiometabolic and endocrine plasma biomarkers in US women. Am J Clin Nutr. 2017; 105: 432-41.

[143] Nilsson A, Halvardsson P, Kadi F. Adherence to DASH-Style Dietary Pattern Impacts on Adiponectin and Clustered Metabolic Risk in Older Women. Nutrients. 2019; 11: 805.

[144] Beygi M, Ahi S, Zolghadri S, Stanek A. Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions. Nutrients. 2024; 16: 2220.

[145] Millstein R. Aerobic Exercise. In: Gellman MD, Turner JR, editors. Encyclopedia of Behavioral Medicine. New York (NY): Springer New York; 2013. pp. 48-9.

[146] Liguori G. ACSM’S Guidelines for Exercise Testing and Prescription. 11th ed. Wolters Kluwer Health; 2021.

[147] Ratamess NA, Alvar BA, Evetoch TK, Housh TJ, Kibler WB, Kraemer WJ, et al. Progression Models in Resistance Training for Healthy Adults. Med Sci Sports Exerc. 2009; 41: 687-708.

[148] Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK, et al.; American College of Sports Medicine Position Stand. Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults. Med Sci Sports Exerc. 2009; 41: 459-71.

[149] Davis ME, Blake C, Perrotta C, Cunningham C, O’Donoghue G. Impact of training modes on fitness and body composition in women with obesity: A systematic review and meta-analysis. Obesity (Silver Spring). 2022; 30: 300-19.

[150] Mohr M, Sjúrðarson T, Skoradal MB, Nordsborg NB, Krustrup P. Long-term continuous exercise training counteracts the negative impact of the menopause transition on cardiometabolic health in hypertensive women - a 9-year RCT follow-up. Prog Cardiovasc Dis. 2024; 85: 54-62.

[151] Yeh ML, Liao RW, Hsu CC, Chung YC, Lin JG. Exercises improve body composition, cardiovascular risk factors and bone mineral density for menopausal women: A systematic review and meta-analysis of randomized controlled trials. Appl Nurs Res. 2018; 40: 90-8.

[152] Aiello EJ, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Bowen D, et al. Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause. 2004; 11: 382-8.

[153] Dupuit M, Maillard F, Pereira B, Marquezi ML, Lancha AH Jr, Boisseau N. Effect of high intensity interval training on body composition in women before and after menopause: a meta-analysis. Exp Physiol. 2020; 105: 1470-90.

[154] Vecchiatto B, da Silva RC, Higa TS, Muller CR, Américo ALV, Fortunato-Lima VC, et al. Oxidative phenotype induced by aerobic physical training prevents the obesity-linked insulin resistance without changes in gastrocnemius muscle ACE2-Angiotensin(1-7)-Mas axis. Diabetol Metab Syndr. 2021; 13: 74.

[155] Khan AR, Alnoud MAH, Ali H, Ali I, Ahmad S, Ul Hassan SS, et al. Beyond the beat: A pioneering investigation into exercise modalities for alleviating diabetic cardiomyopathy and enhancing cardiac health. Curr Probl Cardiol. 2024; 49: 102222.

[156] You T, Murphy KM, Lyles MF, Demons JL, Lenchik L, Nicklas BJ. Addition of aerobic exercise to dietary weight loss preferentially reduces abdominal adipocyte size. Int J Obes (Lond). 2006; 30: 1211-6.

[157] Higa TS, Spinola AV, Fonseca-Alaniz MH, Evangelista FS. Remodeling of white adipose tissue metabolism by physical training prevents insulin resistance. Life Sci. 2014; 103: 41-8.

[158] Nigro P, Middelbeek RJW, Alves CRR, Rovira-Llopis S, Ramachandran K, Rowland LA, et al. Exercise Training Promotes Sex-Specific Adaptations in Mouse Inguinal White Adipose Tissue. Diabetes. 2021; 70: 1250-64.

[159] Pistor KE, Sepa-Kishi DM, Hung S, Ceddia RB. Lipolysis, lipogenesis, and adiposity are reduced while fatty acid oxidation is increased in visceral and subcutaneous adipocytes of endurance-trained rats. Adipocyte. 2014; 4: 22-31.

[160] Chen N, Cheng J, Zhou L, Lei T, Chen L, Shen Q, et al. Effects of treadmill running and rutin on lipolytic signaling pathways and TRPV4 protein expression in the adipose tissue of diet-induced obese mice. J Physiol Biochem. 2015; 71: 733-42.

[161] Enevoldsen LH, Stallknecht B, Langfort J, Petersen LN, Holm C, Ploug T, et al. The effect of exercise training on hormone-sensitive lipase in rat intra-abdominal adipose tissue and muscle. J Physiol. 2001; 536: 871-7.

[162] Rocha-Rodrigues S, Rodríguez A, Gonçalves IO, Moreira A, Maciel E, Santos S, et al. Impact of physical exercise on visceral adipose tissue fatty acid profile and inflammation in response to a high-fat diet regimen. Int J Biochem Cell Biol. 2017; 87: 114-24.

[163] Américo ALV, Muller CR, Vecchiatto B, Martucci LF, Fonseca-Alaniz MH, Evangelista FS. Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose tissue. PLoS One. 2019; 14: e0215896.

[164] Muller CR, Américo ALV, Fiorino P, Evangelista FS. Aerobic exercise training prevents kidney lipid deposition in mice fed a cafeteria diet. Life Sci. 2018; 211: 140-6.

[165] Allerton TD, Savoie JJ, Fitch MD, Hellerstein MK, Stephens JM, White U. Exercise reduced the formation of new adipocytes in the adipose tissue of mice in vivo . PLoS One. 2021; 16: e0244804.

[166] Stotzer US, Rodrigues MF, Domingos MM, Silva GH, Duarte FO, Gatto CV, et al. Resistance Training Suppresses Intra-abdominal Fatty Acid Synthesis in Ovariectomized Rats. Int J Sports Med. 2015; 36: 226-33.

[167] Kang S, Park KM, Sung KY, Yuan Y, Lim ST. Effect of Resistance Exercise on the Lipolysis Pathway in Obese Pre- and Postmenopausal Women. J Pers Med. 2021; 11: 874.

[168] de Melo DG, Anaruma CP, da Cruz Rodrigues KC, Pereira RM, de Campos TDP, Canciglieri RS, et al. Strength training alters the tissue fatty acids profile and slightly improves the thermogenic pathway in the adipose tissue of obese mice. Sci Rep. 2022; 12: 6913.

[169] Vidal P, Stanford KI. Exercise-Induced Adaptations to Adipose Tissue Thermogenesis. Front Endocrinol (Lausanne). 2020; 11: 270.

[170] Fu P, Zhu R, Jia J, Hu Y, Wu C, Cieszczyk P, et al. Aerobic exercise promotes the functions of brown adipose tissue in obese mice via a mechanism involving COX2 in the VEGF signaling pathway. Nutr Metab (Lond). 2021; 18: 56.

[171] Thirupathi A, da Silva Pieri BL, Queiroz JAMP, Rodrigues MS, de Bem Silveira G, de Souza DR, et al. Strength training and aerobic exercise alter mitochondrial parameters in brown adipose tissue and equally reduce body adiposity in aged rats. J Physiol Biochem. 2019; 75: 101-8.

[172] Martinez-Tellez B, Sanchez-Delgado G, Acosta FM, Alcantara JMA, Amaro-Gahete FJ, Martinez-Avila WD, et al. No evidence of brown adipose tissue activation after 24 weeks of supervised exercise training in young sedentary adults in the ACTIBATE randomized controlled trial. Nat Commun. 2022; 13: 5259.

[173] Otero-Díaz B, Rodríguez-Flores M, Sánchez-Muñoz V, Monraz-Preciado F, Ordoñez-Ortega S, Becerril-Elias V, et al. Exercise Induces White Adipose Tissue Browning Across the Weight Spectrum in Humans. Front Physiol. 2018; 9: 1781.

[174] Picoli CC, Gilio GR, Henriques F, Leal LG, Besson JC, Lopes MA, et al. Resistance exercise training induces subcutaneous and visceral adipose tissue browning in Swiss mice. J Appl Physiol (1985). 2020; 129: 66-74.

[175] Coqueiro AY, Raizel R, Bonvini A, Godois ADM, Hypólito TM, Pereira JRR, et al. Effects of Glutamine and Alanine Supplementation on Adiposity, Plasma Lipid Profile, and Adipokines of Rats Submitted to Resistance Training. J Diet Suppl. 2019; 16: 676-88.

[176] Tanaka R, Fuse-Hamaoka S, Kuroiwa M, Kurosawa Y, Endo T, Kime R, et al. The Effects of 10-Week Strength Training in the Winter on Brown-like Adipose Tissue Vascular Density. Int J Environ Res Public Health. 2022; 19: 10375.

[177] Lim S, Choi SH, Jeong I, Kim JH, Moon MK, Park KS, et al. Insulin-Sensitizing Effects of Exercise on Adiponectin and Retinol-Binding Protein-4 Concentrations in Young and Middle-Aged Women. J Clin Endocrinol Metab. 2008; 93: 2263-8.

[178] Moghadasi M, Mohebbi H, Rahmani-Nia F, Hassan-Nia S, Noroozi H, Pirooznia N. High-intensity endurance training improves adiponectin mRNA and plasma concentrations. Eur J Appl Physiol. 2012; 112: 1207-14.

[179] Garekani ET, Mohebbi H, Kraemer RR, Fathi R. Exercise training intensity/volume affects plasma and tissue adiponectin concentrations in the male rat. Peptides. 2011; 32: 1008-12.

[180] Ribeiro HQT, Coqueiro AY, Lima VBS, Martins CEC, Tirapegui J. Leucine and resistance training improve hyperglycemia, white adipose tissue loss, and inflammatory parameters in an experimental model of type 1 diabetes. Nutr Health. 2018; 24: 19-27.

[181] Ward LJ, Nilsson S, Hammar M, Lindh-Åstrand L, Berin E, Lindblom H, et al. Resistance training decreases plasma levels of adipokines in postmenopausal women. Sci Rep. 2020; 10: 19837.

[182] Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB. Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders. Front Endocrinol (Lausanne). 2016; 7: 30.

[183] Polak J, Klimcakova E, Moro C, Viguerie N, Berlan M, Hejnova J, et al. Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor α in obese women. Metabolism. 2006; 55: 1375-81.

[184] Higa TS, Bergamo FC, Mazzucatto F, Fonseca-Alaniz MH, Evangelista FS. Physical training prevents body weight gain but does not modify adipose tissue gene expression. Braz J Med Biol Res. 2012; 45: 988-94.

[185] Leal-Cerro A, Garcia-Luna PP, Astorga R, Parejo J, Peino R, Dieguez C, et al. Serum Leptin Levels in Male Marathon Athletes before and after the Marathon Run. J Clin Endocrinol Metab. 1998; 83: 2376-9.

[186] Zafeiridis A, Smilios I, Considine RV, Tokmakidis SP. Serum leptin responses after acute resistance exercise protocols. J Appl Physiol (1985). 2003; 94: 591-7.

[187] Nindl BC, Kraemer WJ, Arciero PJ, Samatallee N, Leone CD, Mayo MF, et al. Leptin concentrations experience a delayed reduction after resistance exercise in men. Med Sci Sports Exerc. 2002; 34: 608-13.

[188] Vecchiatto B, de Castro TL, Muller CR, Azevedo-Martins AK, Evangelista FS. Physical Exercise-Induced FGF-21 to Fight Obesity: An Update Review. Obesities. 2022; 2: 372-9.

[189] Wu F, Wang B, Zhang S, Shi L, Wang Y, Xiong R, et al. FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice. Clin Sci (Lond). 2017; 131: 1877-93.

[190] Shams S, Tavasolian M, Amani-Shalamzari S, Motamedi P, Rajabi H, Weiss K, et al. Effects of swimming in cold water on lipolysis indicators via fibroblast growth factor-21 in male Wistar rats. Biochem Biophys Rep. 2024; 38: 101662.

[191] Pontes LPP, Alves Nakakura FC, Neto NIP, Boldarine VT, Maza PK, Santos PF, et al. Resistance and Aerobic Training Were Effective in Activating Different Markers of the Browning Process in Obesity. Int J Mol Sci. 2023; 25: 275.

[192] Farzanegi P. Aerobic and Resistance Exercises Modulate Fibroblast Growth Factor-21 (FGF21) Level in Menopause Women with Type II Diabetic. West Indian Medical Journal. 2022; 69: 471.

[193] Tanimura R, Kobayashi L, Shirai T, Takemasa T. Effects of exercise intensity on white adipose tissue browning and its regulatory signals in mice. Physiol Rep. 2022; 10: e15205.

[194] He Z, Tian Y, Valenzuela PL, Huang C, Zhao J, Hong P, et al. Myokine/Adipokine Response to “Aerobic” Exercise: Is It Just a Matter of Exercise Load? Front Physiol. 2019; 10: 691.

[195] Félix-Soriano E, Sáinz N, Gil-Iturbe E, Castilla-Madrigal R, Celay J, Fernández-Galilea M, et al. Differential remodeling of subcutaneous white and interscapular brown adipose tissue by long-term exercise training in aged obese female mice. J Physiol Biochem. 2023; 79: 451-65.

[196] Ziegler AK, Damgaard A, Mackey AL, Schjerling P, Magnusson P, Olesen AT, et al. An anti-inflammatory phenotype in visceral adipose tissue of old lean mice, augmented by exercise. Sci Rep. 2019; 9: 12069.

[197] Guedes JM, Pieri BLDS, Luciano TF, Marques SO, Guglielmo LGA, Souza CT. Muscular resistance, hypertrophy and strength training equally reduce adiposity, inflammation and insulin resistance in mice with diet-induced obesity. Einstein (Sao Paulo). 2019; 18: eAO4784.

[198] Tan L, Yan W, Yang W, Kamionka A, Lipowski M, Zhao Z, et al. Effect of exercise on inflammatory markers in postmenopausal women with overweight and obesity: A systematic review and meta-analysis. Exp Gerontol. 2023; 183: 112310.

[199] Son WH, Park HT, Jeon BH, Ha MS. Moderate intensity walking exercises reduce the body mass index and vascular inflammatory factors in postmenopausal women with obesity: a randomized controlled trial. Sci Rep. 2023; 13: 20172.

[200] Baldelli S, Aiello G, Mansilla Di Martino E, Campaci D, Muthanna FMS, Lombardo M. The Role of Adipose Tissue and Nutrition in the Regulation of Adiponectin. Nutrients. 2024; 16: 2436.